financetom
Business
financetom
/
Business
/
Cosmos Health Regains Nasdaq Compliance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cosmos Health Regains Nasdaq Compliance
Jul 19, 2024 9:57 AM

12:29 PM EDT, 07/19/2024 (MT Newswires) -- Cosmos Health ( COSM ) said it has regained compliance with Nasdaq's minimum bid price rule for continued listing on the exchange.

The company said it was notified by Nasdaq that it achieved a closing bid price of at least $1 per common share for 10 straight business days from July 5 to July 18.

Shares of Cosmos Health ( COSM ) were up 1.6% in recent Friday trading.

Price: 1.28, Change: +0.02, Percent Change: +1.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Genuine Parts' Q1 Adjusted Earnings, Net Sales Increase; 2024 Outlook Updated
Genuine Parts' Q1 Adjusted Earnings, Net Sales Increase; 2024 Outlook Updated
Apr 18, 2024
07:18 AM EDT, 04/18/2024 (MT Newswires) -- Genuine Parts ( GPC ) reported Q1 adjusted earnings Thursday of $2.22 per diluted share, up from $2.14 a year earlier. Analysts polled by Capital IQ expected $2.16. Net sales for the quarter ended March 31 were $5.78 billion, up from $5.77 billion a year earlier. Analysts surveyed by Capital IQ expected $5.84...
D.R. Horton's Fiscal Q2 Earnings, Revenue Advance; 2024 Revenue Outlook Raised -- Shares Up Pre-Bell
D.R. Horton's Fiscal Q2 Earnings, Revenue Advance; 2024 Revenue Outlook Raised -- Shares Up Pre-Bell
Apr 18, 2024
07:01 AM EDT, 04/18/2024 (MT Newswires) -- D.R. Horton ( DHI ) reported fiscal Q2 earnings Thursday of $3.52 per diluted share, up from $2.73 a year earlier. Analysts polled by Capital IQ expected $3.05. Revenue for the quarter ended March 31 was $9.11 billion, up from $7.97 billion a year earlier. Analysts surveyed by Capital IQ expected $8.23 billion....
ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing
ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing
Apr 18, 2024
07:22 AM EDT, 04/18/2024 (MT Newswires) -- Richard E Lowenthal, 10% Owner, Director, PRESIDENT AND CEO, on April 16, 2024, sold 100,000 shares in ARS Pharmaceuticals ( SPRY ) for $928,005. Following the Form 4 filing with the SEC, Lowenthal has control over a total of 12,546,116 shares of the company, with 4,126,822 shares held directly and 8,419,294 shares controlled...
Awale Resources to Raise $10 Million in Bought Deal Private Placement
Awale Resources to Raise $10 Million in Bought Deal Private Placement
Apr 18, 2024
07:17 AM EDT, 04/18/2024 (MT Newswires) -- Awale Resources ( AWLRF ) , which lost 14% yesterday, overnight Wednesday said it will raise about $10 million in a bought deal private placement. The company, will will use the funds for its projects in Cote d'Ivoire and for general corporate purposes, will sell roughly 16.1 million units to a syndicate of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved